Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Senior Research Associate

Biomedical Science · Poland · 2025-05-01

Processing Time
161 days
Decision Date
2025-05-01
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing blood-based and digital biomarker diagnostics for complex mental illnesses such as schizophrenia and bipolar disorder. This work utilizes machine learning and cutting-edge analytics to probe immune system behavior for earlier diagnosis and treatment personalization.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's research in neuroimmune signals and psychiatric diagnostics was found to have substantial merit and national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to a strong publication record, high citation count, and significant funding from major research bodies.

3 Balance of Interests Met

On balance, it was determined that the U.S. would benefit from waiving the labor certification requirement given the petitioner's unique contributions to biomedical science.

Why This Petition Was Approved

The petition was approved based on 35 peer-reviewed journal articles with 1,257 citations and an h-index of 17. The petitioner demonstrated significant influence through over 40 peer reviews and editorial board membership for high-impact journals like Molecular Psychiatry. Evidence of international funding from the UK’s Medical Research Council and EU Framework Programmes further satisfied the Dhanasar prongs.

Request for Evidence (RFE)

Successfully Addressed

The EB-1A petition received an RFE regarding the petitioner's extraordinary ability status. The legal team provided additional evidence of global impact and leadership, leading to approval.

RFE Targets
eb2 qualification

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Judging Experience

Similar Cases

Scientist

Research and Development · Czech Republic

WeGreened EB-2 (NIW) approved
New York 339 days 2022-05-23
The petitioner proposes to continue utilizing machine learning, statistical genetics, and bioinformatics software to investigate the genetic risk factors driving neuropsychiatric and neurological diseases such as schizophrenia, bipolar disorder, and Alzheimer’s disease. The work aims to provide the scientific community with improved tools to characterize these conditions and support the development of advanced treatments.
View Case

Postdoctoral Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 595 days 2025-09-10
The petitioner proposes to identify and analyze neurobiological markers in normal and impaired brain functioning to improve early detection of psychiatric illnesses and neurodegenerative conditions. This research utilizes advanced techniques like patch-clamp electrophysiology and optogenetics to develop evidence-based therapeutic strategies. The work aims to reduce the economic burden of psychiatric illnesses and improve mental health care outcomes in the U.S.
View Case

Others

Research and Development · Turkey

WeGreened EB-2 (NIW) approved
New York 62 days 2025-02-04
The petitioner proposes to develop computational models, non-invasive techniques, and machine learning approaches to identify neural mechanisms behind psychosocial disabilities and mental disorders. This work aims to enhance diagnostic precision and therapeutic interventions to improve outcomes for individuals with psychotic disorders.
View Case

Researcher

Research and Development · Pakistan

WeGreened EB-2 (NIW) approved
New York 218 days 2022-10-05
The petitioner proposes to investigate the biomechanics of the human brain using novel neurological sequencing techniques to reduce the burden of mental illness. Her work specifically focuses on the analysis of schizophrenia and other disorders like Alzheimer’s and diabetes to develop new treatments and psychotherapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Poland

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-01.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 161 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Poland All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist